Hsu's Andrology

What Hsu's Andrology does

Hsu's Andrology is a private medical practice headquartered in Taipei, Taiwan, founded and operated by Dr. Geng-Long Hsu, specializing in microsurgical male potency reconstruction. The practice serves men with erectile dysfunction unresponsive to phosphodiesterase-5 inhibitors, Peyronie's/congenital penile curvature, varicocele, and penile dysmorphology. Its core service portfolio comprises five outpatient surgical procedures — Penile Venous Stripping Surgery (PVSS), penile curvature correction, penile implantation, varicocelectomy, and physiological penile enhancement — plus a supporting glans enhancement adjunct for implant patients and inguinal hernia repair. All procedures are performed exclusively under local anesthesia (with a proprietary acupuncture-assisted protocol developed in 1988) on a true outpatient basis, with most operations completed in under six hours.

The underlying technology stack is centered on proprietary anatomical discoveries: the bilayered structure of the tunica albuginea (1991–1992, UCSF post-doctoral research) and the de novo penile venous anatomy blueprint (1999). These discoveries underpin the USPTO-patented PVSS method (Patent No. US 8,240,313 B2, valid through ~2031), the Factual Penile Girth Enhancement (FPGE) using autologous venous grafts, and the glans enhancement technique for implant patients. The practice claims a 90.9% success rate in improving erectile function post-PVSS, with peer-reviewed clinical evidence including IIEF-5 score improvements from 9.7±2.8 to 20.8±2.3 and patient satisfaction of 81.3% in the FPGE cohort.

The business model is fee-for-service professional services revenue from individual surgical procedures, with no subscription, recurring, or usage-based components and no public pricing. Go-to-market is direct-to-consumer via two Taipei clinic locations (Shilin Main Office and Neihu Branch), supplemented by physician-to-physician referrals, peer-observation of live surgeries, and a heavy academic publication footprint (including five chapters in Elsevier's Encyclopedia of Reproduction across the 2018 and 2026 editions). Customer acquisition is long-tail, with patients self-referring or being referred by urologists, vascular surgeons, and plastic surgeons; some international medical tourism is observed. The practice operates as a sole proprietorship under Dr. Hsu with no external investors, parent company, or subsidiary structure.

Name

Hsu's Andrology

Legal name

HSU'S ANDROLOGY

Website

https://glhsu.org

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

251–500 employees

Short description

Hsu's Andrology is a private Taipei-based microsurgical practice led by Dr. Geng-Long Hsu, specializing in outpatient male potency reconstruction — including erectile dysfunction surgery, penile implantation, curvature correction, varicocelectomy, and enhancement — all performed under local anesthesia.

Ownership category

akta.pro rank

Headquarters

HQ city

Taipei

HQ country

Taiwan

HQ region

Asia

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D

Revenue model

1. Surgical Procedure Fees: Fee-for-service revenue model based on individual surgical procedures. Procedures include penile venous stripping surgery, curvature correction, penile implantation, varicocelectomy, and penile enhancement. All surgeries performed under local anesthesia on an outpatient basis. No subscription, recurring, or usage-based models.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Hsu's Andrology is a Taipei-based medical practice specializing in microsurgical male potency reconstruction. The clinic performs outpatient surgical procedures under local anesthesia, including penile venous stripping surgery, curvature correction, penile prosthesis implantation, varicocelectomy, and penile enhancement. The practice is led by Dr. Geng-Long Hsu and operates under a proprietary anatomical-physiological approach protected by a USPTO patent.

Product overview

Hsu's Andrology is a medical practice specializing in microsurgical male potency reconstruction, led by Dr. Geng-Long Hsu. The practice operates from Taipei, Taiwan, offering a portfolio of outpatient surgical services performed exclusively under local anesthesia. The core services include Penile Venous Stripping (with USPTO patent until 2031), Penile Curvature Correction, Penile Implantation, Varicocelectomy, and Penile Enhancement procedures. The practice also offers hernia repair and uses a distinctive Acupuncture-Assisted Local Anesthesia protocol. All procedures are performed on a true outpatient basis, with claims of completing operations in under 6 hours. The practice has documented over 3,000 penile venous stripping cases since June 1986, 201 penile implants, and 736 curvature correction procedures.

Differentiator

Problem solved

Functional benefit

Products and services

• Penile Venous Stripping Surgery Microsurgical removal of erection-related veins (deep dorsal vein, cavernosal veins, para-arterial veins) to restore natural erection function in men with erectile dysfunction, performed under local anesthesia on outpatient basis. USPTO-patented technique (Patent No. US 8,240,313).
• Penile Curvature Correction Surgical correction of congenital penile deviation and Peyronie's disease using modified Nesbit procedure or autologous venous patch grafting techniques, performed under local anesthesia on outpatient basis.
• Penile Implantation Outpatient penile prosthesis implantation under local anesthesia, including semirigid, malleable, two-piece (AMS Ambicor, Mentor Mark II), and three-piece inflatable prostheses (AMS 700 series, Mentor α 1).
• Varicocelectomy Outpatient surgical procedure involving high ligation of internal spermatic veins for treatment of varicocele, performed under local anesthesia. Reported to increase sperm quantity and enhance libido.
• Physiologically Anatomical Penile Enhancement Penile lengthening and enlargement surgery combining Penile Venous Stripping Surgery (PVSS) with Factual Penile Girth Enhancement (FPGE) using autologous venous walls grafted to tunica albuginea for corporeal augmentation.
• Implant Plus Enhancement Combined penile implant with enhancement surgery for patients seeking both erectile function restoration and penile size augmentation. Includes venous ligation of retrocoronal plexus and deep dorsal veins for glans enhancement.
• Hernia Repair Inguinal, abdominal, and femoral hernia repair surgery performed on outpatient basis under local anesthesia, including combined procedures with other services.
• Acupuncture-Assisted Local Anesthesia Innovative local anesthesia protocol using acupuncture at acupoints (Hegu LI4, Shou San Li LI10, Quchi LI11, Neiguan PE6, Shen Men H7) combined with proximal dorsal nerve block, peripenile infiltration, penile crural block, and cavernous nerve blockade for outpatient penile surgeries.

Quantifiable outcome

• 90.9% success rate in dramatically improving erectile function after penile venous stripping surgery
• +4 more outcomes

Named customers2 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators8 records

Recent moves5 records

Expansion highlights4 records

Others

• Coloplast: Manufacturer of penile implants (Titan touch, Genesis) and other surgical urology devices. Directly comparable as a supplier/enabler of the penile implantation service line at Hsu's Andrology, and a reference competitor in the broader ED-treatment ecosystem.
• Boston Scientific (AMS / Men's Health division): Manufacturer of the AMS 700 inflatable penile prosthesis line and Ambicor two-piece implants — both of which Hsu's Andrology uses. Compares as an upstream device manufacturer enabling the penile implantation service line and competing indirectly in the ED-treatment ecosystem.

Regional players

• Apollo Hospitals: Asia's largest hospital chain, operating across India and parts of Asia, offering broad urology and men's health services. Comparable as a regional incumbent that could compete for inbound medical-tourism ED patients in the same Asian geography as Hsu's Andrology.
• Raffles Medical Group: Large integrated private healthcare provider operating across Asia (strong presence in Singapore, China, and regional Asia-Pacific markets). Compares as a regional incumbent that could expand into specialty men's health/ED services in the same geographies Hsu's Andrology draws patients from.

Direct peers

• Boston Medical Group: Global network of men's health clinics specializing in erectile dysfunction treatment using proprietary combination protocols. Most direct competitor to Hsu's Andrology in the niche of procedural, clinic-based ED care delivered outside mainstream hospital systems.

Broad incumbents

• Mayo Clinic Urology: World-renowned urology department within a major US academic medical center, offering penile implants and ED treatment. Compares as a broad incumbent operating ED/surgical services within a large integrated health system rather than as a boutique specialty practice.
• Cleveland Clinic Men's Health: Major US academic medical center offering comprehensive men's health including urology, sexual medicine, and penile implant surgery. Comparable as a broad incumbent offering overlapping ED and penile surgery services as part of a much larger health system portfolio.
• Johns Hopkins Brady Urological Institute: Leading academic urology department offering men's health, prosthetic urology, and Peyronie's/curvature surgery. Comparable as a broad incumbent with overlapping men's health surgical services, though operating under mainstream academic urology protocols rather than Hsu's proprietary venous-stripping methodology.

Emerging players

• Hims & Hers Health: DTC men's health platform focused primarily on telehealth + PDE-5 inhibitor delivery but expanding into procedural ED treatment. Comparable as a competitor addressing the same patient demand (ED non-responders) via a fundamentally different delivery model (digital-first pharmacy versus microsurgical).
• Roman (now Hims): DTC men's health brand (now part of Hims & Hers) historically focused on telehealth ED treatment. Comparable as a DTC competitor pursuing the same patient segment with a non-procedural, medication-led model.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/hsu-s-andrology

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hsu's Andrology